Biopsy Devices Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Biopsy Devices Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The biopsy devices market size has grown strongly in recent years. It will grow from $2.87 billion in 2023 to $3.11 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to emerging markets growth, advancement in healthcare infrastructure and growth in the elderly population..

The biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.29 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to government investments in healthcare sector, rising cancer cases and an increase in healthcare expenditure will drive the market growth. . Major trends in the forecast period include technological advancements, launch of fully automatic biopsy systems, product innovations, development of robot-assisted biopsy systems, partnerships and collaborations and increasing investments..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp

Market Segmentation:
The biopsy devices market covered in this report is segmented -

1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products
2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies
3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications
4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

Major Driver - Rising Cancer Incidence Drives Robust Growth In The Biopsy Devices Market
The rise in the number of cancer cases contributed to the growth of the biopsy devices market. A biopsy is a primary approach used by doctors to diagnose any abnormalities in the bodies if the presence of cancer cells is suspected. For instance, in January 2023, the American Cancer Society, a US-based a nationwide voluntary health organization dedicated to eliminating cancer, stated that around 1.9 million new cancer cases are anticipated to be diagnosed in the United States in 2022, with an estimated 609,360 cancer-related deaths. Specifically, approximately 151,030 new cases of colorectal cancer are expected to be identified by the end of 2022, and it is projected to lead to roughly 52,550 deaths in 2023. Furthermore, in May 2022, Canadian Medical Association Journal, a Canada-based peer-reviewed open-access general medical journal published by the Canadian Medical Association, in its report stated that in Canada, it is estimated that approximately 233,900 new cases of cancer will be diagnosed in 2022. Among these cases, around 28,600 are projected to be breast cancer, constituting approximately 25% of all newly diagnosed cancer cases in women for that year. The most prevalent type of cancer anticipated in Canada in 2022 is lung cancer, with an estimated 30,000 new cases.

Competitive Landscape:
Major companies operating in the biopsy devices market report are Becton Dickinson and Company (BD), Hologic, Inc., Danaher Corporation, Boston Scientific Corporation, Olympus Corporation, Cook Medical, Medtronic Inc, Cardinal Health, Argon Medical Devices Inc., Fujifilm Holdings Corp, A&T Corporation, BMA Co. Ltd., Transmed (China) Co., LTD, HaploX Biotechnology, Gene+sLab, Lepu Medical Technology, Digirad Corporation, CMR Naviscan Corporation, DDD Diagnostics, Philips Healthcare, Siemens Healthineers, Abbott Laboratories, Bangs Laboratories Inc, Roche Diagnostics, Cepheid, Devicor Medical Products, Braile Biomedica Ltd, B.Braun Medical Gulf, Stryker ESCS BV

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Top Trend - Robot-Assisted Biopsy Systems Revolutionize The Biopsy Devices Market For Enhanced Precision And Safety
Robot-assisted biopsy systems are shaping the biopsy devices market and help avoid complications after the biopsy. The robot-assisted biopsy is done to increase the precision and accuracy of the biopsy process and medical authorities have been approving the devices to make the process easier. For instance, in July 2022, the FDA cleared SiemensHealthineers' and Intuitive's platforms to make a robotic-assisted platform for minimally invasive lung biopsies. The integration would allow 2D and 3D imaging during procedures.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Biopsy Devices Market Characteristics
3. Biopsy Devices Market Trends And Strategies
4. Biopsy Devices Market - Macro Economic Scenario
5. Biopsy Devices Market Size And Growth
…..
27. Biopsy Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.